imuran 50 mg por tbl flm 100x50mg - Resultados de la búsqueda

Chile - español - ISPC (Instituto de Salud Pública de Chile)

avon naturals hands mãos fresa y chocolate blanco piel tersa y cremosa crema humectante para las manos morango e chocolate branco pele macia e cremosa creme hidratante para as mãos

cosmÉticos avon s.a. - sin formulas

Chile - español - ISPC (Instituto de Salud Pública de Chile)

faces natura gloss roll on, brillo labial morango con chocolate

natura cosmÉticos s.a. - sin formulas

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

carnitech 100% beef protein sabor morango .. polvo para solucion oral

lab nutrition corp s.a.c. - droguerÍa - polvo para solucion oral - por dosis 35.00 g - - otros productos para el tracto alimentario y metabolismo

Unión Europea - español - EMA (European Medicines Agency)

mhyosphere pcv id

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - cerdos - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.